Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 24

Cited In for PubMed (Select 2863873)

1.

Neuropsychological and cerebral morphometric aspects of negative symptoms in schizophrenia: negative symptomatology is associated with specific mnestic deficits in schizophrenic patients.

Hornig T, Valerius G, Feige B, Bubl E, Olbrich HM, van Elst LT.

BMC Psychiatry. 2014 Nov 25;14:326. doi: 10.1186/s12888-014-0326-4.

2.

Schizophrenia and autism as contrasting minds: neural evidence for the hypo-hyper-intentionality hypothesis.

Ciaramidaro A, Bölte S, Schlitt S, Hainz D, Poustka F, Weber B, Bara BG, Freitag C, Walter H.

Schizophr Bull. 2015 Jan;41(1):171-9. doi: 10.1093/schbul/sbu124. Epub 2014 Sep 9.

PMID:
25210055
3.

Bridging disparate symptoms of schizophrenia: a triple network dysfunction theory.

Nekovarova T, Fajnerova I, Horacek J, Spaniel F.

Front Behav Neurosci. 2014 May 30;8:171. doi: 10.3389/fnbeh.2014.00171. eCollection 2014.

4.

The longitudinal interplay between negative and positive symptom trajectories in patients under antipsychotic treatment: a post hoc analysis of data from a randomized, 1-year pragmatic trial.

Chen L, Johnston JA, Kinon BJ, Stauffer V, Succop P, Marques TR, Ascher-Svanum H.

BMC Psychiatry. 2013 Nov 28;13:320. doi: 10.1186/1471-244X-13-320.

5.

Deconstructing negative symptoms of schizophrenia: avolition-apathy and diminished expression clusters predict clinical presentation and functional outcome.

Strauss GP, Horan WP, Kirkpatrick B, Fischer BA, Keller WR, Miski P, Buchanan RW, Green MF, Carpenter WT Jr.

J Psychiatr Res. 2013 Jun;47(6):783-90. doi: 10.1016/j.jpsychires.2013.01.015. Epub 2013 Feb 27.

6.

Lack of gender influence on cortical and subcortical gray matter development in childhood-onset schizophrenia.

Weisinger B, Greenstein D, Mattai A, Clasen L, Lalonde F, Feldman S, Miller R, Tossell JW, Vyas NS, Stidd R, David C, Gogtay N.

Schizophr Bull. 2013 Jan;39(1):52-8. doi: 10.1093/schbul/sbr049. Epub 2011 May 25.

7.
8.

Treatment outcomes of patients with tardive dyskinesia and chronic schizophrenia.

Caroff SN, Davis VG, Miller DD, Davis SM, Rosenheck RA, McEvoy JP, Campbell EC, Saltz BL, Riggio S, Chakos MH, Swartz MS, Keefe RS, Stroup TS, Lieberman JA; CATIE Investigators.

J Clin Psychiatry. 2011 Mar;72(3):295-303. doi: 10.4088/JCP.09m05793yel. Epub 2010 Aug 10.

9.

The brief negative symptom scale: psychometric properties.

Kirkpatrick B, Strauss GP, Nguyen L, Fischer BA, Daniel DG, Cienfuegos A, Marder SR.

Schizophr Bull. 2011 Mar;37(2):300-5. doi: 10.1093/schbul/sbq059. Epub 2010 Jun 17.

10.

Temporal lobe structures and facial emotion recognition in schizophrenia patients and nonpsychotic relatives.

Goghari VM, Macdonald AW 3rd, Sponheim SR.

Schizophr Bull. 2011 Nov;37(6):1281-94. doi: 10.1093/schbul/sbq046. Epub 2010 May 19.

11.

Cognitive impairment in schizophrenia and affective psychoses: implications for DSM-V criteria and beyond.

Bora E, Yücel M, Pantelis C.

Schizophr Bull. 2010 Jan;36(1):36-42. doi: 10.1093/schbul/sbp094. Epub 2009 Sep 23. Review.

12.

The functional neuroanatomy of symptom dimensions in schizophrenia: a qualitative and quantitative review of a persistent question.

Goghari VM, Sponheim SR, MacDonald AW 3rd.

Neurosci Biobehav Rev. 2010 Mar;34(3):468-86. doi: 10.1016/j.neubiorev.2009.09.004. Epub 2009 Sep 20. Review.

13.

Differences in glucose tolerance between deficit and nondeficit schizophrenia.

Kirkpatrick B, Fernandez-Egea E, Garcia-Rizo C, Bernardo M.

Schizophr Res. 2009 Feb;107(2-3):122-7. doi: 10.1016/j.schres.2008.09.023. Epub 2008 Nov 28.

14.

Longitudinal progression of negative symptoms in schizophrenia: a new look at an old problem.

Kelley ME, Haas GL, van Kammen DP.

Schizophr Res. 2008 Oct;105(1-3):188-96. doi: 10.1016/j.schres.2008.06.003. Epub 2008 Jul 11.

15.

Life events and high-trait reactivity together predict psychotic symptom increases in schizophrenia.

Docherty NM, St-Hilaire A, Aakre JM, Seghers JP.

Schizophr Bull. 2009 May;35(3):638-45. doi: 10.1093/schbul/sbn002. Epub 2008 Jan 31.

16.

Deconstructing and reconstructing illness syndromes associated with psychosis.

Carpenter WT.

World Psychiatry. 2007 Jun;6(2):92-3. No abstract available.

17.

Do symptom dimensions or categorical diagnoses best discriminate between known risk factors for psychosis?

Allardyce J, McCreadie RG, Morrison G, van Os J.

Soc Psychiatry Psychiatr Epidemiol. 2007 Jun;42(6):429-37. Epub 2007 May 14.

18.

Persistent negative symptoms in schizophrenia: an overview.

Buchanan RW.

Schizophr Bull. 2007 Jul;33(4):1013-22. Epub 2006 Nov 10. Review.

19.

Symptom dimensions and outcome in schizophrenia.

Salokangas RK.

World Psychiatry. 2003 Oct;2(3):172-8.

20.

Functional brain mapping of psychopathology.

Honey GD, Fletcher PC, Bullmore ET.

J Neurol Neurosurg Psychiatry. 2002 Apr;72(4):432-9. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk